Spots Global Cancer Trial Database for pertuzumab + trastuzumab + docetaxel
Every month we try and update this database with for pertuzumab + trastuzumab + docetaxel cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Her2-positive Lung Cancer Treated With Dedicated Drug | NCT03845270 | Non Small Cell ... Non Small Cell ... HER2 Gene Mutat... | pertuzumab + tr... | 18 Years - | Intergroupe Francophone de Cancerologie Thoracique |